VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-29.75%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
-$369M
(-60%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-76.23%
Top 10 Holdings %
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94
Top Buys
| 1 |
Newmont
NEM
|
$1.82M |
| 2 |
COR
Coresite Realty Corporation
COR
|
$1.7M |
| 3 |
Public Storage
PSA
|
$1.53M |
| 4 |
Brookfield Renewable
BEP
|
$1.51M |
| 5 |
Avista
AVA
|
$1.44M |
Top Sells
| 1 |
Reliance Steel & Aluminium
RS
|
$4.3M |
| 2 |
Vale
VALE
|
$4.14M |
| 3 |
DEA
Easterly Government Properties
DEA
|
$4.07M |
| 4 |
NP
Neenah, Inc. Common Stock
NP
|
$4.04M |
| 5 |
Arbor Realty Trust
ABR
|
$3.91M |
Sector Composition
| 1 | Financials | 20.56% |
| 2 | Healthcare | 19.87% |
| 3 | Real Estate | 12.49% |
| 4 | Energy | 9.44% |
| 5 | Materials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GARS
176
DELISTED
Garrison Capital Inc.
GARS
| $470K | 0.19% |
276,462
-112,772
| -29% | -$192K |
|
177
Ironwood Pharmaceuticals
IRWD
$188M
| $464K | 0.19% |
46,003
-3,882
| -8% | -$39.2K |
|
178
Neurocrine Biosciences
NBIX
$14.3B
| $461K | 0.19% |
5,322
-449
| -8% | -$38.9K |
|
|
CCXI
179
DELISTED
ChemoCentryx, Inc.
CCXI
| $460K | 0.19% |
11,447
-1,668
| -13% | -$67K |
|
180
Enanta Pharmaceuticals
ENTA
$189M
| $454K | 0.19% |
8,831
-745
| -8% | -$38.3K |
|
181
Axsome Therapeutics
AXSM
$6.25B
| $452K | 0.19% |
7,688
-1,113
| -13% | -$65.4K |
|
182
Agios Pharmaceuticals
AGIO
$2.09B
| $447K | 0.18% |
12,600
-1,063
| -8% | -$37.7K |
|
183
Ionis Pharmaceuticals
IONS
$9.76B
| $441K | 0.18% |
9,329
-787
| -8% | -$37.2K |
|
184
Sarepta Therapeutics
SRPT
$1.96B
| $436K | 0.18% |
4,457
-376
| -8% | -$36.8K |
|
|
AKCA
185
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $436K | 0.18% |
30,486
-2,573
| -8% | -$36.8K |
|
186
Viper Energy
VNOM
$6.29B
| $435K | 0.18% |
65,625
-54,794
| -46% | -$363K |
|
|
ITCI
187
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $431K | 0.18% |
28,050
-4,089
| -13% | -$62.8K |
|
|
PRNB
188
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $430K | 0.18% |
7,235
-1,042
| -13% | -$61.9K |
|
189
Alector
ALEC
$305M
| $429K | 0.18% |
17,794
-2,590
| -13% | -$62.4K |
|
190
Akebia Therapeutics
AKBA
$785M
| $427K | 0.18% |
56,270
-8,206
| -13% | -$62.3K |
|
191
Fate Therapeutics
FATE
$116M
| $425K | 0.17% |
19,135
-2,782
| -13% | -$61.8K |
|
192
Quince Therapeutics
QNCX
$86.5M
| $420K | 0.17% |
9,198
-1,355
| -13% | -$61.9K |
|
|
TBIO
193
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $415K | 0.17% |
41,612
-6,073
| -13% | -$60.6K |
|
194
Iovance Biotherapeutics
IOVA
$901M
| $412K | 0.17% |
13,751
-2,013
| -13% | -$60.3K |
|
|
ONC
195
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $412K | 0.17% |
3,343
-282
| -8% | -$34.8K |
|
196
Insmed
INSM
$30.7B
| $406K | 0.17% |
25,355
-2,139
| -8% | -$34.3K |
|
197
Ligand Pharmaceuticals
LGND
$3.25B
| $403K | 0.17% |
8,892
-750
| -8% | -$34K |
|
198
Cytokinetics
CYTK
$6.34B
| $398K | 0.16% |
33,754
-4,932
| -13% | -$58.2K |
|
|
KRTX
199
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $397K | 0.16% |
5,516
-790
| -13% | -$56.9K |
|
|
GBT
200
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $391K | 0.16% |
7,657
-646
| -8% | -$33K |
|